AgingResearch.NewsJoin free

Lactobacillus acidophilus 1244

Lactobacillus acidophilus 1244 has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 7, 2024: “Lactobacillus paracasei subsp. paracasei 2004 improves health and lifespan in Caenorhabditis elegans”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funder: National Institutes of Health
  • 1 of 1 finding with company ties
  • Model organisms1

What did studies of Lactobacillus acidophilus 1244 find?

1

Studies of Lactobacillus acidophilus 1244 measured 1 outcome; the most studied are oxidative stress and ROS signaling (1 study).

Oxidative stress and ROS signaling

downin worms1

1 study

  1. Lactobacillus acidophilus 1244 protects against oxidative stress and ROS signaling in worms.

    “Supplementation with the lactic acid bacterial strains L. acidophilus 1244 or L. paracasei subsp. paracasei 2004 significantly improved health, including food consumption, motility, and resistance to oxidative stressor, hydrogen peroxide”

    Model organismsresistance to hydrogen peroxide

    Lactobacillus paracasei subsp. paracasei 2004 improves health and lifespan in Caenorhabditis elegans

    Scientific reports

More on Oxidative stress and ROS signaling

Latest

Related